Chemoinformaics analysis of 8-Deoxy-11-hydroxy-13-chlorogrosheimin
| Molecular Weight | 298.766 | nRot | 1 |
| Heavy Atom Molecular Weight | 279.614 | nRig | 18 |
| Exact Molecular Weight | 298.097 | nRing | 3 |
| Solubility: LogS | -2.941 | nHRing | 1 |
| Solubility: LogP | 1.841 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 19 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 43.1071 |
| nHD | 1 | BPOL | 23.0429 |
| QED | 0.454 |
| Synth | 4.985 |
| Natural Product Likeliness | 2.989 |
| NR-PPAR-gamma | 0.013 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.002 |
| HIA | 0.035 |
| CACO-2 | -4.985 |
| MDCK | 0.0000224 |
| BBB | 0.992 |
| PPB | 0.654495 |
| VDSS | 0.749 |
| FU | 0.291096 |
| CYP1A2-inh | 0.03 |
| CYP1A2-sub | 0.563 |
| CYP2c19-inh | 0.027 |
| CYP2c19-sub | 0.747 |
| CYP2c9-inh | 0.015 |
| CYP2c9-sub | 0.171 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.505 |
| CYP3a4-inh | 0.138 |
| CYP3a4-sub | 0.421 |
| CL | 11.996 |
| T12 | 0.162 |
| hERG | 0.014 |
| Ames | 0.079 |
| ROA | 0.741 |
| SkinSen | 0.034 |
| Carcinogencity | 0.792 |
| EI | 0.017 |
| Respiratory | 0.174 |
| NR-Aromatase | 0.078 |
| Antiviral | Yes |
| Prediction | 0.78795 |